Papillary Thyroid Cancer

specific

A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the n

36

Centers

33

Active Trials

$4M

Cancer Funding

Top Centers for Papillary Thyroid Cancer(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
High-Volume Research Center
83.0
2
Boston University Cancer CenterBoston, MA
High-Volume Research Center
71.3
3
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
High-Volume Research Center
71.2
4
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
High-Volume Research Center
70.1
5
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
66.9
6
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
Active Research Program
66.9
7
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
66.9
8
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
Active Research Program
53.4
9
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
53.2
10
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
53.2
11
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
53.2
12
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
53.2
13
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
Active Research Program
53.2
14
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
53.2
15
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
53.2
16
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
53.2
17
Georgetown Lombardi Comprehensive Cancer CenterWashington, DC
NCI Comprehensive
Active Research Program
53.2
18
University of Illinois Cancer CenterChicago, IL
Active Research Program
53.2
19
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
53.2
20
Cancer Center at IllinoisUrbana, IL
Active Research Program
53.2
21
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
53.2
22
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
53.2
23
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
53.2
24
Princess Margaret Cancer CentreToronto, ON
Active Research Program
53.2
25
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
53.2
26
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
Active Research Program
51.5
27
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
34.4
28
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
34.4
29
Medical College of Wisconsin Cancer CenterMilwaukee, WI
34.4
30
Cleveland Clinic Cancer CenterCleveland, OH
34.4
31
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
34.4
32
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
34.4
33
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
34.4
34
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
34.4
35
Upstate Cancer CenterSyracuse, NY
34.4
36
BC CancerVancouver, BC
34.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →